Abstract
The incidence of atherosclerosis and cardiovascular disease (CVD) in women increases following menopause and has been associated with a reduction in circulating estrogen. Increased CVD risk is also perpetuated by sedentary lifestyle. Growing evidence indicates that oxidation of lipoproteins leads to a powerful immune response, disruption of normal lipoprotein function, and deposition of atherosclerotic plaques. For example, once high-density lipoproteins (HDL) are oxidized, they lose the ability to a) participate in reverse transport of cholesterol to the liver, and b) protect low-density lipoproteins (LDL) against oxidation. The purpose of this study was to determine the effects of combining estrogen replacement and exercise upon lipid peroxidation of the HDL fraction (HDL-ox). Blood samples were drawn from 34 post-menopausal women from four groups: women who were not receiving estrogen replacement and who were sedentary (NSD) (n = 9); women who were not receiving estrogen replacement and who were participating in regular exercise (NEX) (n = 8); women who were receiving estrogen replacement and who were sedentary (ESD) (n = 8); and women who were receiving estrogen replacement and who were participating in regular exercise (EEX) (n = 9). Total-HDL cholesterol was significantly higher (p<0.05) in EEX when compared with NEX, NSD, and ESD. HDL-ox was assessed via malondialdehyde (MDA). Mean (± SEM) values for HDL MDA expressed in nM are as follows: NSD = 903.3 ± 118.4; NEX = 1226.7 ± 247.7; ESD = 876.7 ± 116.3; EEX = 537.4 ± 74.8. EEX lipid peroxidation was significantly (p = 0.02) lower than NEX. Lipid peroxidation tended to be lower in EEX than in NSD and ESD (p = 0.07). These data indicate that the combination of estrogen replacement and regular exercise in post-menopausal women may be most effective in reducing oxidation of HDL in vivo.
Key words
Atherosclerosis - cardiovascular disease - free radicals - high density lipoproteins - hormone replacement therapy
References
-
1
Ayres S, Tang M, Subbiah M T.
Estradiol-17ß as an antioxidant: some distinct features when compared with common fat-soluble antioxidants.
J Lab Clin Med .
1996;
128
367-375
-
2
Beard CM, Barnard R J, Robbins D C, Ordovas J M, Schaefer EJ.
Effects of diet and exercise on qualitative and quantitative measures of LDL and its susceptibility to oxidation.
Arterioscl Thromb Vasc Bio.
1996;
16
201-207
-
3
Berliner J A, Naveb M, Fogelman A M, Frank J S, Demer L L, Edwardes P A, Watson A D, Lusis A J.
Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics.
Circulation.
1995;
91
2488-2496
-
4
Bowling N, Matter W F, Gadski R A, McClure D B, Schreyer T, Dawson P A, lahos O J.
LY295427, a novel hypocholesterolemic agent, enhances [3H]25-hydroxycholesterol binding to liver cytosolic proteins.
J Lipid Res.
1996;
37
2586-2598
-
5
Bowry V W, Stanley K K, Stocker R.
High density lipoprotein is the major carrier of hydroperoxides in human blood plasma from fasting donors.
Proc Natl Acad Sci.
1992;
89
10 316-10 320
-
6
Bruckert E, Turpin G.
Estrogens and progestins in post-menopausal women: influence on lipid parameters and cardiovascular risk.
Hormone Res.
1995;
43
100-103
-
7
Brochier M L, Arwidson P.
Coronary heart disease risk factors in women.
Eur Heart J.
1998;
19
A45-A52
-
8
Christison J K, Rye K A, Stocker R.
Exchange of oxidized cholesteryl linoleate between LDL and HDL by cholesterol ester transfer protein.
J Lipid Res.
1995;
36
2017-2026
-
9
Criswell DS, Powers S, Dodd S, Lawler J, Edwards W, Renshler K, Grinton S.
Cellular oxidative and antioxidant response in skeletal muscle to interval and continuous exercise training.
Med Sci Sports Exer.
1993;
25
1135-1140
-
10
Devaraj S, Jialal T.
Oxidized low-density lipoprotein and atherosclerosis.
Int J Clin Lab Res.
1996;
26
178-184
-
11
de Waart F G, Moser U, Kok F J.
Vitamin E supplementation in elderly lowers the oxidation rate of linoleic acid in LDL.
Atherosclerosis.
1997;
133
255-263
-
12
Egeland G M, Kuller K H, Matthews K A, Kelsey S F, Cauley J, Guzick D.
Hormone replacement therapy and lipoprotein changes during early menopause.
Obstetr Gynecol.
1990;
76
776-782
-
13
Folsom A R, Mink P J, Sellers T A, Hong C P, Zheng W, Potter J D.
Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women.
Am J Pub Health.
1995;
85
1128-1132
-
14
Fruebis J, Ginzalez V, Silvestre M, Palinski W.
Effect of probucol treatment on gene expression of VCAM-1, MCP-1, and M-CSF.
Arterioscl Thromb Vasc Biol.
1995;
17
1289-1302
-
15
Gohil K, Viguie S, Stanley W C, Brooks G A, Packer L.
Blood glutathione oxidation during human exercise.
J Appl Physiol.
1988;
64
115-119
-
16
Goldstein J L, Ho Y K, Basu S K, Brown M S.
Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein producing massive cholesterol deposition.
Proc Natl Acad Soc USA.
1979;
76
333-337
-
17
Görög P.
Activation of human blood monocytes by oxidized polyunsaturated fatty acids: a possible mechanism for generation of lipid peroxides in circulation.
Int J Exp Pathol.
1991;
72
227-237
-
18
Gutteridge J MC, Quinlan G J.
Malondialdehyde formation in the thiobarbituric acid test: the role of lipid radicals, iron salts, and metal chelators.
J Appl Biochem.
1983;
5
293-299
-
19
Hahn M, Subbiah M T.
Significant association of lipid peroxidation products with high density lipoproteins.
Biochem Mol Biol Internat.
1994;
33
699-704
-
20
Heikkinen A M, Niskanen L, Yla-Herttuala S, Luoma J, Tuppruainen M T, Kamulainen M, Saarikoski S.
Postmenopausal hormone replacement therapy and autoantibodies against oxidized LDL.
Maturitus.
1998;
29
155-161
-
21
Ji L L, Stratman F W, Lardy H A.
Enzymatic downregulation with exercise in rat skeletal muscle.
Arch Biochem Biophys.
1988;
263
137-149
-
22
Kanter M M, Hamlin R L, Unverferth D V, Davis H W, Merola A J.
Effect of exercise training on antioxidant enzymes and cardiotoxicity of doxorubicin.
J Appl Physiol.
1986;
59
1298-1303
-
23
Kihlstöm M.
Protection effect of endurance training against reoxygenation-induced injuries in the rat heart.
J Appl Physiol.
1990;
68
1672-1678
-
24
Kwiterovich P G Jr.
The antiatherogenic role of high density lipoprotein cholesterol.
Am J Cardiol.
1998;
82
13Q-21Q
-
25
Lawler J M, Powers S K, Visser T, VanDijk H, Kordus M, Ji L L.
Acute exercise and skeletal muscle antioxidant and metabolic enzymes: effects of fiber-type and age.
Am J Physiol.
1993;
265
R1344-R1350
-
26
Mahfouz M M, Kawano H, Kummerow F A.
Effect of cholesterol-rich diets with and without added vitamins E and C on the severity of atherosclerosis in rabbits.
Am J Clin Nutr.
1997;
66
1240-1249
-
27
Martin A, Frei B.
Both intracellular and extracellular Vitamin C inhibit atherogenic modification of LDL by human vascular endothelial cells.
Arterioscl Thromb Vasc Biol.
1997;
17
1583-1590
-
28
McManus J, McEneny J, Thompson W, Young L S.
The effect of hormone replacement therapy on the oxidation of low density lipoprotein in postmenopausal women.
Atherosclerosis.
1997;
135
73-81
-
29
McManus J, McEneny J, Young L S, Thompson W.
The effect of various oestrogens and progestogens on the susceptibility of low density lipoproteins to oxidation in vitro.
Maturitus.
1996;
25
125-131
-
30
Mehta J L, Chen L Y.
Reversal of high-density lipoproteins of the effect of oxidized low-density lipoprotein on nitric oxide synthase protein expression in human platelets.
J Lab Clin Med.
1996;
127
287-295
-
31
Mena P, Maynar M, Gutierrez J M, Maynar J, Timon J, Campillo J E.
Erythrocyte free radical scavenger enzymes in bicycle professional racers: adaptation to exercise.
Int J Sports Med.
1991;
12
563-566
-
32
Morgan N A, Colling C L, Fye C L.
Cardiovascular diseases in women: an equal opportunity killer.
J Am Pharmaceut Assoc.
1996;
36
360-369
-
33
Ohkawa H, Ohishi N, Yagi K.
Assay for lipid peroxidation in animal tissues by thiobarbituric acid reaction.
Anal Biochem.
1979;
95
371-379
-
34
Ohmura H, Watanabe Y, Hatsumi C, Sato H, Daida H, Mokuno H, Yamaguchi H.
Possible role of high susceptibility of high-density lipoprotein to lipid peroxidative modification and oxidized high-density lipoprotein in genesis of coronary artery spasm.
Atherosclerosis.
1999;
142
179-184
-
35
Palinski W, Yla-Herttuala S, Rosenfeld M E, Butler S W, Socher S A, Parthasarathy S, Curtiss L K, Witztum J L.
Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein.
Arteriosclerosis.
1990;
10
325-335
-
36
Palmer H J, Paulson K E.
Reactive oxygen species and antioxidants in signal transduction and gene expression.
Nutr Rev.
1997;
55
353-361
-
37
Panasenko O M, Vol'nova TV, Azizova OA, Vladimirov Y A.
Free radical modification of lipoproteins and cholesterol accumulation in cells upon atherosclerosis.
Free Rad Biol Med.
1991;
10
137-148
-
38
Pati N, Pati U.
Paraoxonase gene polymorphism and coronary artery disease in Indian subjects.
Int J Cardiol.
1999;
66
165-168
-
39
Powers S K, Criswell D, Lawler J M, Martin D, Lieu F K, Ji L L, Herb R.
Rigorous exercise training increases superoxide dismutase activity in the ventricular myocardium.
Am J Physiol.
1993;
265
H2094-H2098
-
40
Rifici V A, Khachadurian A K.
Effects of dietary vitamin C and E supplementation on the copper mediated oxidation of HDL and on HDL mediated cholesterol efflux.
Atherosclerosis.
1996;
127
19-26
-
41
Robertson J D, Maughan R J, Duthie G G, Morrice P C.
Increased blood antioxidant systems of runners in response to training load.
Clin Sci.
1991;
80
611-618
-
42
Samsioe G.
Cardioprotection by estrogens: mechanisms of action - the lipids.
Int J Fert Menopaus Stud.
1994;
39
43-49
-
43
Sanchez-Quesada J L, Ortega H, Payes-Romero J, Serrat-Serrat J, Gonzalez-Sastre F, Lasuncion M A, Ordonez-Llanos J.
LDL from aerobically-trained subjects shows higher resistance to oxidative modification than LDL from sedentary subjects.
Atherosclerosis.
1997;
132
207-213
-
44
Steinberg D.
Arterial metabolism of lipoproteins in relation to atherogenesis.
Ann NY Acad Sci.
1990;
598
125-135
-
45
Suc I, Escargueil-Blanc I, Troly M, Salvayre R, Negre-Salvayre A.
HDL and ApoA prevent cell death of endothelial cells induced by oxidized LDL.
Arterioscl Thromb Vasc Biol.
1997;
17
2158-2166
-
46
Taichakraichana N, Limpaphayom K, Ninlagarn T, Panyakhamlerd K, Chaikittisilpa S, Dusitsin N.
A randomized trial of oral contraceptive and hormone replacement therapy on bone mineral density and coronary heart disease risk factors in postmenopausal women.
Obstetr Gynecol.
2000;
95
87-94
-
47
Vasankari T J, Kujala U M, Vasankari T M, Ahotupa M.
Reduced oxidized LDL levels after a 10-month exercise program.
Med Sci Sports Exer.
1998;
30
1496-1501
-
48
Wakatsuki A, Ikenoue N, Sagara Y.
Effects of estrogen on susceptibility to oxidation of low-density and high-density lipoprotein in postmenopausal women.
Maturitus.
1998;
28
229-234
-
49
Wander R C, Du S H, Ketchum S D, Rowe K E.
Effects of interaction of RRR-alpha-tocopherol acetate and fish oil on low-density-lipoprotein oxidation in postmenopausal women with and without hormone-replacement therapy.
Am J Clin Nutr.
1996;
63
184-193
-
50
Wells G, Herrington D M.
The Heart and Estrogen/Progestin Replacement Study: what have we learned and what questions remain.
Drugs Aging.
1999;
15
419-422
-
51
Wetzstein C J, Sherry-Brewer R A, Santanam N, Green N R, White-Welkley J E, Parthasarathy S.
Does acute exercise affect the susceptibility of low density lipoprotein to oxidation?.
Free Rad Biol Med.
1998;
24
679-682
-
52 Wilmore J H, Costill D L. Physiology of Sport and Exercise. Champaign, IL; Human Kinetics 1999: 132-624
J. M. Lawler
Redox Biology & Cell Signaling Laboratory · Department of Health and Kinesiology · Texas A&M University
Rm 276B Read Bldg. · College Station · TX 77843-4243 · USA ·
Phone: (+1) 979 862 2038
Fax: (+1) 979 847 8987
Email: jml2621@neo.tamu.edu
